AstraZeneca shares gain as coronavirus vaccine trials resume




  • In US
  • 2020-09-14 07:15:41Z
  • By Reuters
AstraZeneca shares gain as coronavirus vaccine trials resume
AstraZeneca shares gain as coronavirus vaccine trials resume  

(Reuters) - Shares of AstraZeneca <AZN.L> inched higher in early trade on Monday as the optimism spurred by the British drugmaker's resumption of clinical trials for its COVID-19 vaccine candidate outweighed official weekend moves to cut U.S. drug prices.

The stock was the biggest boost to London's bluechip, FTSE 100 <.FTSE> index in early trading, but quickly pared gains as U.S. President Donald Trump's order to lower prices nationally hurt pharmaceutical stocks across the board.

AstraZeneca shares were trading at 8,431 pence by 0833 GMT. UK pharma stocks <.FTNMX4570>, however, underperformed the FTSE 100, with GSK <GSK.L> down 0.2% and Hikma <HIK.> 1% on Trump's order.

The resumption of the trials for AstraZeneca's vaccine, one of the most advanced in development and regarded by governments and financial markets as one of the best bets to tackle the health crisis in the months ahead, buoyed stock markets around the world.

Late-stage trials of the vaccine were suspended last week after an illness in a study participant, casting doubts on an early rollout and sending the London-listed company's shares lower.

Global trials of the vaccine had also been paused following the UK suspension. Brazil has approved restarting the trials and the Serum Institute of India is awaiting permission from the Drugs Controller General of India.

Cambridge-based AstraZeneca's shares had risen about 11% this year up to their Friday close of 8,429 pence, giving the pharmaceutical giant a market capitalisation of 111 billion pounds ($142 billion).


(Graphic: AstraZeneca vs FTSE 100, https://fingfx.thomsonreuters.com/gfx/buzz/azgponoekvd/Pasted%20image%201600064759673.png)


(Reporting by Pushkala Aripaka in Bengaluru; Editing by Saumyadeb Chakrabarty and Anil D'Silva)

COMMENTS

More Related News

Ruth Bader Ginsburg: Republicans vow to vote on Trump pick
Ruth Bader Ginsburg: Republicans vow to vote on Trump pick

Senate leader Mitch McConnell said he will push ahead within hours of Supreme Court justice's death.

Trump
Trump's 'maximum pressure' peaks just before election
  • World
  • 2020-09-19 11:00:47Z

The president is promoting himself as a Middle East peacemaker just as he amps up pressure on Iran after dismantling a landmark international agreement with the country.

Ruth Bader Ginsburg death: How has Trump
Ruth Bader Ginsburg death: How has Trump's Supreme Court changed America?

This court has been billed the most conservative in modern history. But does it vote that way?

This is what happens when a Supreme Court justice dies or steps down before the election
This is what happens when a Supreme Court justice dies or steps down before the election

Justice Ruth Bader Ginsburg died on Friday at age 87. The Senate majority leader has said he would push for filling a vacancy even in an election year.

U.S. Supreme Court Justice Ginsburg dies at age 87 from pancreatic cancer
U.S. Supreme Court Justice Ginsburg dies at age 87 from pancreatic cancer

Justice Ruth Bader Ginsburg, a stalwart liberal on the U.S. Supreme Court since 1993, died on Friday at age 87, the court said, giving President Donald Trump a chance to expand its conservative majority with a third appointment at a time of deep divisions in America with a presidential election looming

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: US